D
CorMedix Inc.
CRMD
$6.30
$0.233.79%
D
Sell
3/14/2023Downgrade
CorMedix Inc. (CRMD) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
CorMedix Inc. (CRMD) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
CorMedix Inc. (CRMD) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
CorMedix Inc. (CRMD) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
CorMedix Inc. (CRMD) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
CorMedix Inc. (CRMD) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
11/14/2022Upgraded
CorMedix Inc. (CRMD) was upgraded to D from D- on 11/14/2022 due to an increase in the growth index and solvency index. EBIT increased 15.52% from -$8.24M to -$6.96M, and earnings per share increased from -$0.1913 to -$0.17.
CorMedix Inc. (CRMD) was upgraded to D from D- on 11/14/2022 due to an increase in the growth index and solvency index. EBIT increased 15.52% from -$8.24M to -$6.96M, and earnings per share increased from -$0.1913 to -$0.17.
D
Sell
11/8/2022Downgrade
CorMedix Inc. (CRMD) was downgraded to D- from D on 11/8/2022 due to a noticeable decline in the growth index, total return index and volatility index. EBIT declined 17.18% from -$7.03M to -$8.24M, and earnings per share declined from -$0.1839 to -$0.1913.
CorMedix Inc. (CRMD) was downgraded to D- from D on 11/8/2022 due to a noticeable decline in the growth index, total return index and volatility index. EBIT declined 17.18% from -$7.03M to -$8.24M, and earnings per share declined from -$0.1839 to -$0.1913.
D
Sell
5/5/2022Upgraded
CorMedix Inc. (CRMD) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index and growth index.
CorMedix Inc. (CRMD) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index and growth index.
D
Sell
4/20/2022Downgrade
CorMedix Inc. (CRMD) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index.
CorMedix Inc. (CRMD) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index.
D
Sell
11/10/2021Upgraded
CorMedix Inc. (CRMD) was upgraded to D from D- on 11/10/2021 due to an increase in the volatility index and valuation index.
CorMedix Inc. (CRMD) was upgraded to D from D- on 11/10/2021 due to an increase in the volatility index and valuation index.
D
Sell
11/8/2021Downgrade
CorMedix Inc. (CRMD) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the total return index and volatility index.
CorMedix Inc. (CRMD) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the total return index and volatility index.
D
Sell
9/7/2021Downgrade
CorMedix Inc. (CRMD) was downgraded to D from D+ on 9/7/2021 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 26.63 to 25.06.
CorMedix Inc. (CRMD) was downgraded to D from D+ on 9/7/2021 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 26.63 to 25.06.
D
Sell
7/8/2021Upgraded
CorMedix Inc. (CRMD) was upgraded to D+ from D on 7/8/2021 due to an increase in the total return index and valuation index.
CorMedix Inc. (CRMD) was upgraded to D+ from D on 7/8/2021 due to an increase in the total return index and valuation index.
D
Sell
6/8/2021Downgrade
CorMedix Inc. (CRMD) was downgraded to D from D+ on 6/8/2021 due to a decline in the volatility index and total return index.
CorMedix Inc. (CRMD) was downgraded to D from D+ on 6/8/2021 due to a decline in the volatility index and total return index.
D
Sell
5/17/2021Upgraded
CorMedix Inc. (CRMD) was upgraded to D+ from D on 5/17/2021 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 11.14 to 26.63.
CorMedix Inc. (CRMD) was upgraded to D+ from D on 5/17/2021 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 11.14 to 26.63.
D
Sell
3/18/2020Upgraded
CorMedix, Inc. (CRMD) was upgraded to D from D- on 3/18/2020 due to a noticeable increase in the efficiency index and valuation index.
CorMedix, Inc. (CRMD) was upgraded to D from D- on 3/18/2020 due to a noticeable increase in the efficiency index and valuation index.
D
Sell
3/9/2020Upgraded
CorMedix, Inc. (CRMD) was upgraded to D- from E+ on 3/9/2020 due to an increase in the growth index, volatility index and valuation index.
CorMedix, Inc. (CRMD) was upgraded to D- from E+ on 3/9/2020 due to an increase in the growth index, volatility index and valuation index.
E
Sell
11/19/2019Downgrade
CorMedix, Inc. (CRMD) was downgraded to E+ from D- on 11/19/2019 due to a decline in the growth index, total return index and efficiency index. Earnings per share declined from -$0.0292 to -$1.3477, operating cash flow declined 2,509.91% from $164.5 to -$3.96M, and net income declined 656.22% from -$696.2 to -$5.26M.
CorMedix, Inc. (CRMD) was downgraded to E+ from D- on 11/19/2019 due to a decline in the growth index, total return index and efficiency index. Earnings per share declined from -$0.0292 to -$1.3477, operating cash flow declined 2,509.91% from $164.5 to -$3.96M, and net income declined 656.22% from -$696.2 to -$5.26M.
D
Sell
8/19/2019Downgrade
CorMedix, Inc. (CRMD) was downgraded to D- from D on 8/19/2019 due to a decline in the efficiency index and valuation index.
CorMedix, Inc. (CRMD) was downgraded to D- from D on 8/19/2019 due to a decline in the efficiency index and valuation index.
D
Sell
5/15/2019Upgraded
CorMedix, Inc. (CRMD) was upgraded to D from D- on 5/15/2019 due to a noticeable increase in the solvency index, efficiency index and volatility index. The quick ratio increased from 2.27 to 6.05, total capital increased 107.72% from $11.06M to $22.97M, and debt to equity declined from 1.24 to 0.39.
CorMedix, Inc. (CRMD) was upgraded to D from D- on 5/15/2019 due to a noticeable increase in the solvency index, efficiency index and volatility index. The quick ratio increased from 2.27 to 6.05, total capital increased 107.72% from $11.06M to $22.97M, and debt to equity declined from 1.24 to 0.39.
D
Sell
3/29/2019Downgrade
CorMedix, Inc. (CRMD) was downgraded to D- from D+ on 3/29/2019 due to a major decline in the efficiency index and valuation index.
CorMedix, Inc. (CRMD) was downgraded to D- from D+ on 3/29/2019 due to a major decline in the efficiency index and valuation index.
D
Sell
12/18/2018Upgraded
CorMedix, Inc. (CRMD) was upgraded to D+ from D on 12/18/2018 due to a substantial increase in the total return index, volatility index and growth index. Total revenue increased 4,801.32% from $7.6 to $372.5.
CorMedix, Inc. (CRMD) was upgraded to D+ from D on 12/18/2018 due to a substantial increase in the total return index, volatility index and growth index. Total revenue increased 4,801.32% from $7.6 to $372.5.
D
Sell
8/16/2018Upgraded
CorMedix, Inc. (CRMD) was upgraded to D from D- on 8/16/2018 due to a noticeable increase in the efficiency index, valuation index and total return index. Net income increased 15.99% from -$10.19M to -$8.56M.
CorMedix, Inc. (CRMD) was upgraded to D from D- on 8/16/2018 due to a noticeable increase in the efficiency index, valuation index and total return index. Net income increased 15.99% from -$10.19M to -$8.56M.
D
Sell
5/17/2018Downgrade
CorMedix, Inc. (CRMD) was downgraded to D- from D on 5/17/2018 due to a decline in the valuation index, solvency index and volatility index. The quick ratio declined from 1.92 to 0.93.
CorMedix, Inc. (CRMD) was downgraded to D- from D on 5/17/2018 due to a decline in the valuation index, solvency index and volatility index. The quick ratio declined from 1.92 to 0.93.
D
Sell
3/20/2018Upgraded
CorMedix, Inc. (CRMD) was upgraded to D from D- on 3/20/2018 due to a large increase in the growth index, efficiency index and solvency index. Total revenue increased 51.39% from $61.1 to $92.5, and earnings per share increased from -$0.1651 to -$0.1554.
CorMedix, Inc. (CRMD) was upgraded to D from D- on 3/20/2018 due to a large increase in the growth index, efficiency index and solvency index. Total revenue increased 51.39% from $61.1 to $92.5, and earnings per share increased from -$0.1651 to -$0.1554.
D
Sell
5/11/2017Downgrade
CorMedix, Inc. (CRMD) was downgraded to D- from D on 5/11/2017 due to a major decline in the growth index, efficiency index and total return index. Total revenue declined 67.46% from $121.7 to $39.6, total capital declined 38.01% from $17.81M to $11.04M, and net income declined 18.71% from -$6.4M to -$7.6M.
CorMedix, Inc. (CRMD) was downgraded to D- from D on 5/11/2017 due to a major decline in the growth index, efficiency index and total return index. Total revenue declined 67.46% from $121.7 to $39.6, total capital declined 38.01% from $17.81M to $11.04M, and net income declined 18.71% from -$6.4M to -$7.6M.
D
Sell
3/21/2017Upgraded
CorMedix, Inc. (CRMD) was upgraded to D from D- on 3/21/2017 due to a major increase in the growth index and efficiency index. Total revenue increased 173.48% from $44.5 to $121.7, earnings per share increased from -$0.2337 to -$0.1584, and net income increased 29.88% from -$9.13M to -$6.4M.
CorMedix, Inc. (CRMD) was upgraded to D from D- on 3/21/2017 due to a major increase in the growth index and efficiency index. Total revenue increased 173.48% from $44.5 to $121.7, earnings per share increased from -$0.2337 to -$0.1584, and net income increased 29.88% from -$9.13M to -$6.4M.
D
Sell
8/5/2016Downgrade
CorMedix, Inc. (CRMD) was downgraded to D- from D on 8/5/2016 due to a large decline in the growth index, valuation index and efficiency index. Total revenue declined 60.14% from $41.4 to $16.5, net income declined 15.49% from -$4.23M to -$4.89M, and EBIT declined 15.27% from -$4.26M to -$4.91M.
CorMedix, Inc. (CRMD) was downgraded to D- from D on 8/5/2016 due to a large decline in the growth index, valuation index and efficiency index. Total revenue declined 60.14% from $41.4 to $16.5, net income declined 15.49% from -$4.23M to -$4.89M, and EBIT declined 15.27% from -$4.26M to -$4.91M.
D
Sell
5/26/2016Upgraded
CorMedix, Inc. (CRMD) was upgraded to D from D- on 5/26/2016 due to an increase in the valuation index and growth index.
CorMedix, Inc. (CRMD) was upgraded to D from D- on 5/26/2016 due to an increase in the valuation index and growth index.
D
Sell
5/11/2016Downgrade
CorMedix, Inc. (CRMD) was downgraded to D- from D on 5/11/2016 due to a decline in the valuation index, total return index and solvency index. The quick ratio declined from 11.66 to 9.98.
CorMedix, Inc. (CRMD) was downgraded to D- from D on 5/11/2016 due to a decline in the valuation index, total return index and solvency index. The quick ratio declined from 11.66 to 9.98.
D
Sell
3/11/2016Downgrade
CorMedix, Inc. (CRMD) was downgraded to D from C- on 3/11/2016 due to a significant decline in the volatility index, total return index and valuation index.
CorMedix, Inc. (CRMD) was downgraded to D from C- on 3/11/2016 due to a significant decline in the volatility index, total return index and valuation index.
C
Hold
2/22/2016Upgraded
CorMedix, Inc. (CRMD) was upgraded to C- from D+ on 2/22/2016 due to a substantial increase in the volatility index and valuation index.
CorMedix, Inc. (CRMD) was upgraded to C- from D+ on 2/22/2016 due to a substantial increase in the volatility index and valuation index.
D
Sell
11/13/2015Upgraded
CorMedix, Inc. (CRMD) was upgraded to D+ from D on 11/13/2015 due to an increase in the valuation index.
CorMedix, Inc. (CRMD) was upgraded to D+ from D on 11/13/2015 due to an increase in the valuation index.
D
Sell
8/7/2015Downgrade
CorMedix, Inc. (CRMD) was downgraded to D from D+ on 8/7/2015 due to a large decline in the total return index, efficiency index and volatility index. Net income declined 24.78% from -$5.5M to -$4.14M.
CorMedix, Inc. (CRMD) was downgraded to D from D+ on 8/7/2015 due to a large decline in the total return index, efficiency index and volatility index. Net income declined 24.78% from -$5.5M to -$4.14M.
D
Sell
6/2/2015Downgrade
CorMedix, Inc. (CRMD) was downgraded to D+ from C- on 6/2/2015 due to a large decline in the total return index and volatility index.
CorMedix, Inc. (CRMD) was downgraded to D+ from C- on 6/2/2015 due to a large decline in the total return index and volatility index.
C
Hold
5/18/2015Upgraded
CorMedix, Inc. (CRMD) was upgraded to C- from D+ on 5/18/2015 due to a significant increase in the total return index, volatility index and efficiency index. Net income increased 148.28% from -$2.21M to -$5.5M, and total capital increased 109% from $3.63M to $7.6M.
CorMedix, Inc. (CRMD) was upgraded to C- from D+ on 5/18/2015 due to a significant increase in the total return index, volatility index and efficiency index. Net income increased 148.28% from -$2.21M to -$5.5M, and total capital increased 109% from $3.63M to $7.6M.
D
Sell
11/14/2014Downgrade
CorMedix, Inc. (CRMD) was downgraded to D+ from C- on 11/14/2014 due to a decline in the valuation index and growth index. EBIT declined 1.39% from -$1.89M to -$1.86M.
CorMedix, Inc. (CRMD) was downgraded to D+ from C- on 11/14/2014 due to a decline in the valuation index and growth index. EBIT declined 1.39% from -$1.89M to -$1.86M.
C
Hold
9/2/2014Downgrade
CorMedix, Inc. (CRMD) was downgraded to C- from C on 9/2/2014 due to a significant decline in the efficiency index.
CorMedix, Inc. (CRMD) was downgraded to C- from C on 9/2/2014 due to a significant decline in the efficiency index.
C
Hold
8/15/2014Upgraded
CorMedix, Inc. (CRMD) was upgraded to C from C- on 8/15/2014 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 225.41% from $12.2 to $39.7, and operating cash flow increased 5.37% from -$1.43M to -$1.51M.
CorMedix, Inc. (CRMD) was upgraded to C from C- on 8/15/2014 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 225.41% from $12.2 to $39.7, and operating cash flow increased 5.37% from -$1.43M to -$1.51M.
C
Hold
5/16/2014Upgraded
CorMedix, Inc. (CRMD) was upgraded to C- from D+ on 5/16/2014 due to a large increase in the solvency index, growth index and efficiency index. Total revenue increased 510% from $2 to $12.2, the quick ratio increased from 1.42 to 8.2, and net income increased 386.52% from -$3.44M to -$16.71M.
CorMedix, Inc. (CRMD) was upgraded to C- from D+ on 5/16/2014 due to a large increase in the solvency index, growth index and efficiency index. Total revenue increased 510% from $2 to $12.2, the quick ratio increased from 1.42 to 8.2, and net income increased 386.52% from -$3.44M to -$16.71M.
D
Sell
4/17/2014Downgrade
CorMedix, Inc. (CRMD) was downgraded to D+ from C- on 4/17/2014 due to a decline in the total return index and efficiency index. Total capital declined 151.97% from -$1.2M to $625.6.
CorMedix, Inc. (CRMD) was downgraded to D+ from C- on 4/17/2014 due to a decline in the total return index and efficiency index. Total capital declined 151.97% from -$1.2M to $625.6.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
